
Wellbutrin SR
Tobacco Dependence, Major Depressive Disorder
150mg
Wellbutrin SR is bupropion 150mg in a modified-release tablet for tobacco dependence and major depression, a weak reuptake inhibitor of two amines.
Bupropion affects noradrenaline and dopamine signalling. Different products may be used for depression or smoking cessation, while a combination product has a separate role in weight management.

Tobacco Dependence, Major Depressive Disorder
150mg
Wellbutrin SR is bupropion 150mg in a modified-release tablet for tobacco dependence and major depression, a weak reuptake inhibitor of two amines.

Major Depressive Disorder, Tobacco Dependence
150 · 300mg
Bupropion 150mg and 300mg modified-release tablets, used in the management of major depression and tobacco dependence. An aminoketone antidepressant.
Listings are for comparison only. Suitability and supply depend on clinician and pharmacy checks, stock, destination rules and prescription requirements.
Bupropion may be used for depression or smoking cessation and tobacco dependence. In combination with another ingredient, it may be used for selected people with obesity.
Bupropion inhibits reuptake of noradrenaline and dopamine. The intended outcome and treatment plan depend on the formulation and indication.
Seizure risk, blood pressure, bipolar symptoms, pregnancy, alcohol or sedative use, monoamine-oxidase inhibitors and all products containing bupropion require review. Mood and behaviour changes should be reported promptly, especially after starting or changing treatment.
Seek emergency help for a seizure, suicidal intent, immediate risk of harm, severe confusion or agitation, facial swelling, breathing difficulty or a painful blistering rash.